Vext Science, Inc. (VEXTF)
OTCMKTS · Delayed Price · Currency is USD
0.2350
+0.0124 (5.57%)
Sep 10, 2025, 12:46 PM EDT
Vext Science Market Cap
Vext Science has a market cap or net worth of $55.49 million as of September 10, 2025. Its market cap has increased by 24.49% in one year.
Market Cap
55.49M
Enterprise Value
86.12M
Revenue
44.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.24
Market Cap Chart
Since May 13, 2019, Vext Science's market cap has decreased from 78.00M to 55.49M, a decrease of -28.86%. That is a compound annual growth rate of -5.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 55.49M | 95.54% |
| Dec 31, 2024 | 28.38M | -40.58% |
| Dec 29, 2023 | 47.76M | 80.79% |
| Dec 30, 2022 | 26.42M | -61.79% |
| Dec 31, 2021 | 69.14M | -22.72% |
| Dec 31, 2020 | 89.47M | 102.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 739.37M |
| Tian'an Technology Group | 675.94M |
| Glass House Brands | 608.81M |
| CytoDyn | 424.27M |
| Northwest Biotherapeutics | 378.39M |
| American Oncology Network | 353.52M |